News about "Gland Pharma"

Gland Pharma Gets FDA Approval for Phytonadione Injectable Emulsion

The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Vitamin KI1 Injectable Emulsion USP, 10 mg/mL, of Hospira, Inc.

Gland Pharma | 16/12/2024 | By Aishwarya

Six Pharma Firms Plans to Build Green Pharma Units in Telangana

As per the MoUs, the MSN Group will establish a manufacturing unit and an R&D centre and Aurobindo Pharma and Laurus Labs will set up formulation units.

Gland Pharma | 25/11/2024 | By Aishwarya |  103

Gland Pharma Reports Revenue of INR 14,058 Million in Q2FY25

Gland Pharma has reported a consolidated revenue of INR 14,058 million for Q2 FY25, marking a 2 percent increase compared to INR 13,734 million in Q2 FY24.

Gland Pharma | 05/11/2024 | By Aishwarya

Gland Pharma Welcomes Shyamakant Giri as New CEO

Giri is a business leader with over 25 years of strategic and operating experience in pharmaceuticals, devices, diagnostics and healthcare services in Indian and multinational organizations across Asia, Africa, MENA & LATAM markets.

Gland Pharma | 21/10/2024 | By Aishwarya |  133

Gland Pharma Reports 16 Percent YoY Revenue Growth in Q1FY25

Gland Pharma has revealed its financial results for the first quarter of FY25, ending June 30, 2024.

Gland Pharma | 07/08/2024 | By Aishwarya |  118

Gland Pharma Gets Tentative Approval from USFDA for Latanoprostene Bunod Ophthalmic Solution

Gland Pharma Ltd. has secured tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024 percent.

Gland Pharma | 24/07/2024 | By Aishwarya |  249

Gland Pharma Appoints New Executive Chairman and CEO

Gland Pharma Ltd. has announced that Srinivas Sadu has been appointed as Executive Chairman and CEO of the company.

Gland Pharma | 11/06/2024 | By Aishwarya |  216

Gland Pharma Reports Remarkable Q4FY24 and FY24 Financial Performance

Gland Pharma Ltd. has announced its financial results for the fourth quarter (Q4FY24) and full year (FY24) ended on Mar 31, 2024.

Gland Pharma | 23/05/2024 | By Aishwarya |  152

Gland Pharma Receives Nod from US FDA for Rare Muscle Disorder

Gland Pharma Ltd. has received approval from the US health regulator for its generic Edaravone injection to treat amyotrophic lateral sclerosis.

Gland Pharma | 08/05/2024 | By Aishwarya |  150

Gland Pharma Receives USFDA Approval for Cetrorelix Acetate Injection

According to IQVIA, the product had US sales of approximately USD 129 million for the twelve months ending February 2024.

Gland Pharma | 29/04/2024 | By Abha |  196